Exscientia
Exscientia, GlaxoSmithKline ink £33 million AI-driven drug discovery partnership
Exscientia, a company that uses artificial intelligence and machine learning for drug discovery, has entered into a collaboration with GlaxoSmithKline (GSK).
The company will receive...